Ruane, Cunniff & Goldfarb’s Athenahealth, Inc. ATHN Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,441	Closed	-$325K	–	71
2017 Q4	$325K	Sell	2,441 -194,816	-99%	-$24.9M	﹤0.01%	64
2017 Q3	$24.5M	Sell	197,257 -109,187	-36%	-$15M	0.21%	38
2017 Q2	$43.1M	Buy	306,444 +4,288	+1%	+$536K	0.4%	35
2017 Q1	$34M	Hold	302,156	–	–	0.32%	38
2016 Q4	$31.8M	Buy	302,156 +2,061	+0.7%	+$222K	0.3%	41
2016 Q3	$37.8M	Hold	300,095	–	–	0.36%	38
2016 Q2	$41.4M	Buy	300,095 +100,095	+50%	+$13.2M	0.39%	38
2016 Q1	$27.8M	Hold	200,000	–	–	0.22%	43
2015 Q4	$32.2M	Hold	200,000	–	–	0.18%	44
2015 Q3	$26.7M	Hold	200,000	–	–	0.14%	45
2015 Q2	$22.9M	Hold	200,000	–	–	0.11%	48
2015 Q1	$23.9M	Hold	200,000	–	–	0.11%	46
2014 Q4	$29.1M	Hold	200,000	–	–	0.15%	45
2014 Q3	$26.3M	Hold	200,000	–	–	0.14%	50
2014 Q2	$25M	Buy	+200,000	New	+$25.8M	0.13%	49
2014 Q1	–	Sell	-150,000	Closed	-$20.2M	–	148
2013 Q4	$20.2M	Sell	150,000 -150,000	-50%	-$19.3M	0.11%	47
2013 Q3	$32.6M	Hold	300,000	–	–	0.19%	44
2013 Q2	$25.4M	Buy	+300,000	New	+$26.8M	0.16%	44

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's ATHN Position: Q1 2018 in Review

Ruane, Cunniff & Goldfarb sold out of Athenahealth, Inc. (ATHN) in Q1 2018, closing a stake of 2,441 shares — an estimated $325K sold.

Ruane, Cunniff & Goldfarb first reported a position in ATHN in Q2 2013 and held it in 18 quarters. The position peaked at $43.1M in Q2 2017. 259 funds tracked by Wall St. Rank hold ATHN as of Q1 2018.

Ruane, Cunniff & Goldfarb reported no remaining Athenahealth, Inc. position as of Q1 2018 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 2,441 Athenahealth, Inc. shares in Q1 2018, an estimated $325K.
Ruane, Cunniff & Goldfarb first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 18 quarters.
Ruane, Cunniff & Goldfarb's Athenahealth, Inc. position peaked at $43.1M in Q2 2017.
259 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2018.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q1 2018, filed 15 May 2018.